Open AccessAcquired Fanconi Syndrome from Ifosfamide
Author(s) -
Omar Darwish
Publication year - 2020
Publication title -
international journal of case reports and therapeutic studies
Language(s) - English
Resource type - Journals
ISSN - 2689-310X
DOI - 10.24966/crts-310x/100013
Subject(s) - fanconi syndrome , tubulopathy , glycosuria , medicine , aminoaciduria , ifosfamide , renal tubular acidosis , cystinosis , endocrinology , chemotherapy , acidosis , kidney disease , kidney , biology , biochemistry , urine , cystine , enzyme , cysteine , etoposide , diabetes mellitus
Fanconi syndrome is a renal proximal tubule defect that causes reabsorption defects of electrolytes. The clinical features of Fanconi syndrome are amino aciduria, proteinuria, hypophosphatemia, metabolic acidosis, and glycosuria. In children, it is usually resulting from a genetic defect, such as cystinosis, galactosemia, tyrosinemia, hereditary fructose intolerance, and Wilson disease [1]. However, in adults, it is usually resulting from medications, toxins, and kidney diseases such as light chain proximal tubulopathy and primary amyloidosis [1]. Ifosfamide is a chemotherapy agent that is well known in the literature to cause Fanconi syndrome. Herein, we present a case of a woman with cervical cancer who developed ifosfamide-induced Fanconi syndrome after her fifth cycle of chemotherapy.